Cleared Traditional

MICROPROCESSOR CONTR/MULTI-NEEDLE, GALVAN EPILATOR (K864289) - FDA 510(k) Clearance

Class I General & Plastic Surgery device.

K864289 · Alexander Thomas, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1986
Decision
31d
Days
Class 1
Risk

K864289 is an FDA 510(k) clearance for the MICROPROCESSOR CONTR/MULTI-NEEDLE, GALVAN EPILATOR. Classified as Epilator, High Frequency, Needle-type (product code KCW), Class I - General Controls.

Submitted by Alexander Thomas, Inc. (Collingswood, US). The FDA issued a Cleared decision on December 1, 1986 after a review of 31 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.5350 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Alexander Thomas, Inc. devices

Submission Details

510(k) Number K864289 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 31, 1986
Decision Date December 01, 1986
Days to Decision 31 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
84d faster than avg
Panel avg: 115d · This submission: 31d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code KCW Epilator, High Frequency, Needle-type
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 878.5350
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.